Skip to main content
SpringerLink
Log in

Risk of methotrexate-related liver fibrosis may have been overestimated

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Atallah E, et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. Journal of Hepatology : 23 Jan 2023. Available from: URL: http://doi.org/10.1016/j.jhep.2022.12.034

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of methotrexate-related liver fibrosis may have been overestimated. Reactions Weekly 1943, 11 (2023). https://doi.org/10.1007/s40278-023-32896-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32896-8

Search

Navigation